Literature DB >> 28138977

Global epidemiological trends and variations in the burden of gallbladder cancer.

Chandrakanth Are1, Humera Ahmad2, Advaitaa Ravipati3, Darren Croo1, Dillon Clarey1, Lynette Smith4, Ray R Price5, Jean M Butte6, Sameer Gupta7, Arun Chaturvedi7, Sanjib Chowdhury8.   

Abstract

BACKGROUND: The aim of this study is to describe the trends and variations in the global burden of gallbladder cancer (GBC) with an emphasis on geographic variations and female gender.
METHODS: Data (2012-2030) relating to GBC was extracted from GLOBOCAN 2012 database and analyzed.
RESULTS: The results of our study document a rising global burden of GBC with geographic and gender variations. The highest burden was noted in the WPRO region (based on WHO regions), Asia (based on continents) and India, Chile, and China (based on countries). The less developed regions of the world account for the majority of the global burden of GBC. The geographic variations are also present within individual countries such as in India and Chile. Females are afflicted at a much higher rate with GBC and this predilection is exaggerated in countries with higher incidence such as India and Chile. In females, people of certain ethnic groups and lower socio-economic standing are at a higher risk.
CONCLUSIONS: Our study demonstrates a rising global burden of GBC with some specific data on geographic and gender-based variations which can be used to develop strategies at the global as well as the high-risk individual country level.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  GLOBOCAN 2012; WHO regions; demographic shift; gallbladder cancer burden; human development index (HDI)

Mesh:

Year:  2017        PMID: 28138977     DOI: 10.1002/jso.24546

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

1.  Significance of HER2 and Ki-67 in Preneoplastic Lesions and Carcinoma of Gallbladder.

Authors:  Sutapa Halder; Sayan Kundu; Jayati Chakraborty; Sudipta Chakrabarti
Journal:  J Gastrointest Cancer       Date:  2019-12

2.  Incidental Gallbladder Cancer on Cholecystectomy: Strategy for Re-resection of Presumed Benign Diseases from a Retrospective Multicenter Study by the Yokohama Clinical Oncology Group.

Authors:  Ryusei Matsuyama; Kenichi Matsuo; Ryutaro Mori; Mitsutaka Sugita; Naotaka Yamaguchi; Toru Kubota; Kunio Kameda; Yasuhisa Mochizuki; Ryo Takagawa; Toshiaki Kadokura; Goro Matsuda; Noriyuki Kamiya; Itaru Endo
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 3.  Molecular Oncology of Gall Bladder Cancer.

Authors:  Arun Chaturvedi; Vijay Kumar; Sameer Gupta
Journal:  Indian J Surg Oncol       Date:  2019-11-16

4.  Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer.

Authors:  Jie Wang; Xiaobo Bo; Changcheng Wang; Yanlei Xin; Lingxi Nan; Rongkui Luo; Lingli Chen; Xiao Shi; Tao Suo; Xiaoling Ni; Han Liu; Sheng Shen; Min Li; Pinxiang Lu; Yueqi Wang; Houbao Liu
Journal:  Cancer Sci       Date:  2019-12-12       Impact factor: 6.716

5.  Efficacy and Safety of Anti-PD1/PDL1 in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis.

Authors:  Qi Jiang; Jinsheng Huang; Bei Zhang; Xujia Li; Xiuxing Chen; Bokang Cui; Shengping Li; Guifang Guo
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

6.  Target nursing care on anxiety and depression in patients with gallbladder cancer during perioperative period.

Authors:  Shuang Liu; Li Zhang; Xiu-E Guan; Lei Zhang; Rui Wang
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

7.  Publication Trends of Research on Gallbladder Cancer During 2001-2021: A 20-Year Bibliometric Analysis.

Authors:  Wentao Sun; Wenze Wan; Zhihui Gao; Tao Suo; Sheng Shen; Houbao Liu
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

8.  Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T1b gallbladder cancer: An analysis of the surveillance, epidemiology, and end results database (2004 to 2013).

Authors:  Li Xu; Haidong Tan; Xiaolei Liu; Jia Huang; Liguo Liu; Shuang Si; Yongliang Sun; Wenying Zhou; Zhiying Yang
Journal:  Cancer Med       Date:  2020-03-31       Impact factor: 4.452

9.  Trends in Treatment and Survival of Gallbladder Cancer in the Netherlands; Identifying Gaps and Opportunities from a Nation-Wide Cohort.

Authors:  Elise de Savornin Lohman; Tessa de Bitter; Rob Verhoeven; Lydia van der Geest; Jeroen Hagendoorn; Nadia Haj Mohammad; Freek Daams; Heinz-Josef Klümpen; Thomas van Gulik; Joris Erdmann; Marieke de Boer; Frederik Hoogwater; Bas Groot Koerkamp; Andries Braat; Joanne Verheij; Iris Nagtegaal; Cornelis van Laarhoven; Peter van den Boezem; Rachel van der Post; Philip de Reuver
Journal:  Cancers (Basel)       Date:  2020-04-09       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.